AT357261B - Verfahren zur herstellung von cytostatisch wirkenden arzneimittelpraeparaten - Google Patents

Verfahren zur herstellung von cytostatisch wirkenden arzneimittelpraeparaten

Info

Publication number
AT357261B
AT357261B AT714678A AT714678A AT357261B AT 357261 B AT357261 B AT 357261B AT 714678 A AT714678 A AT 714678A AT 714678 A AT714678 A AT 714678A AT 357261 B AT357261 B AT 357261B
Authority
AT
Austria
Prior art keywords
producing
active drug
drug preparations
cytostatically active
cytostatically
Prior art date
Application number
AT714678A
Other languages
English (en)
Other versions
ATA714678A (de
Inventor
Karoly Dr Lapis
Bela Dr Szende
Andras Dr Jeney
Laszlo Dr Kopper
Karoly Dr Simon
Erno Dipl Ing Chem Tyihak
Lajos Dr Dipl Ing Ch Kisfaludy
Lajos Dipl Ing Chem Kovacs
Gyoergy Dipl Ing Chem Dobo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA714678A publication Critical patent/ATA714678A/de
Application granted granted Critical
Publication of AT357261B publication Critical patent/AT357261B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT714678A 1977-10-13 1978-10-04 Verfahren zur herstellung von cytostatisch wirkenden arzneimittelpraeparaten AT357261B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77RI649A HU179753B (en) 1977-10-13 1977-10-13 Process for producting synergetic pharmaceutical compositions of citostatic activity

Publications (2)

Publication Number Publication Date
ATA714678A ATA714678A (de) 1979-11-15
AT357261B true AT357261B (de) 1980-06-25

Family

ID=11001045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT714678A AT357261B (de) 1977-10-13 1978-10-04 Verfahren zur herstellung von cytostatisch wirkenden arzneimittelpraeparaten

Country Status (13)

Country Link
US (1) US4260595A (de)
AT (1) AT357261B (de)
AU (1) AU520724B2 (de)
BE (1) BE871197A (de)
CA (1) CA1108054A (de)
CH (1) CH641672A5 (de)
DE (1) DE2844534A1 (de)
DK (1) DK455278A (de)
FR (1) FR2405710A1 (de)
GB (1) GB2006010B (de)
HU (1) HU179753B (de)
IL (1) IL55644A0 (de)
NL (1) NL7810332A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659699A (en) * 1983-08-22 1987-04-21 Cetus-Ben Venue Therapeutics Process for freeze drying cyclophosphamide
ATE77754T1 (de) * 1988-02-11 1992-07-15 Matrix Pharma Zusammensetzungen zur behandlung von gehirntumoren.

Also Published As

Publication number Publication date
AU520724B2 (en) 1982-02-25
HU179753B (en) 1982-12-28
DE2844534C2 (de) 1988-03-17
FR2405710A1 (fr) 1979-05-11
GB2006010A (en) 1979-05-02
IL55644A0 (en) 1978-12-17
CA1108054A (en) 1981-09-01
NL7810332A (nl) 1979-04-18
DE2844534A1 (de) 1979-04-19
CH641672A5 (de) 1984-03-15
US4260595A (en) 1981-04-07
FR2405710B1 (de) 1981-07-31
DK455278A (da) 1979-04-14
AU4059678A (en) 1980-04-17
ATA714678A (de) 1979-11-15
GB2006010B (en) 1982-06-23
BE871197A (fr) 1979-04-12

Similar Documents

Publication Publication Date Title
LU77562A1 (de) Verfahren zur herstellung von neuen pharmazeutischen praeparaten
AT364451B (de) Verfahren zur herstellung von lokalanaesthetisch wirksamen kombinationspraeparaten
AT371709B (de) Verfahren zur herstellung von pharmazeutischen praeparaten in dosiereinheitsform
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT383271B (de) Verfahren zur herstellung von cerebralwirksamen arzneimitteln
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
AT366576B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
DD133943A5 (de) Verfahren zur herstellung von optisch aktiven azabicycloalkanen
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
DD130036A5 (de) Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen
AT360673B (de) Verfahren zur herstellung von neuen optisch aktiven 11-desoxy-16-aryl-omega-prostaglandinen
AT359197B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT363174B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen
AT347445B (de) Verfahren zur herstellung von optisch aktiven anthracyclinonen
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT357261B (de) Verfahren zur herstellung von cytostatisch wirkenden arzneimittelpraeparaten
DD138202A5 (de) Verfahren zur herstellung von veraetherten cycloalkanolen
AT366574B (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung
AT378915B (de) Verfahren zur herstellung von antihypertensiven pharmazeutischen zubereitungen
AT361641B (de) Verfahren zur herstellung von a-nor-androsta- -3(5), 16-dien-2-on- und a-nor-androsta-3(5),6, 16-trien-2-on-derivaten
ATA136279A (de) Verfahren zur herstellung von pharmazeutischen praeparaten
ATA236577A (de) Verfahren zur herstellung von injektions- praeparaten
AT368992B (de) Verfahren zur herstellung von chlorthioameisens[urealkylestern
DD131467B1 (de) Verfahren zur kontinuierlichen herstellung von acyltauriden
AT348680B (de) Verfahren zur herstellung von arzneipraeparaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee